We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Further Observations on Use of Warfarin Sodium in Anticoagulant Therapy

AMA Arch Intern Med. 1956;97(6):753-757. doi:10.1001/archinte.1956.00250240105009.
Text Size: A A A
Published online


Recent reports * have indicated that therapeutic hypoprothrombinemia may be produced and maintained safely and effectively by the administration of the 4-hydroxycoumarin compound, warfarin sodium.† The rapidity of onset and duration of action of warfarin sodium has suggested that perhaps in instances where prolonged anticoagulant therapy is anticipated warfarin sodium could be administered with less frequency in somewhat larger doses, obviating the necessity for a daily prothrombin determination. This would appear to be a distinct advantage if, after a period of careful observation, a dose could be administered every three or four days that might be predicted with a reasonable degree of accuracy to maintain the prothrombin concentration in an acceptable therapeutic range. Concomitant with good predictability a lessening of the frequency for prothrombin determinations would be realized, with resultant economy.

Our clinical studies were directed by this premise, and presentation of these observations is given, together with a comparison of


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.